ENGOT-EN11/GOG-3053/KEYNOTE-B21
Trial Description:
A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus placebo in combination with adjuvant chemotherapy with or without radiotherapy for the treatment of newly diagnosed High-Risk Endometrial Cancer after surgery with curative Intent
Lead Cooperative Group:
Trial Number:
EudraCT: 2020-003424-17
Disease Site:
Endometrial
Trial Status:
Recruiting
Contact person:
tvgorp